Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gut microbiota and metabolite interface-mediated hepatic inflammation.
Yang M, Massad K, Kimchi ET, Staveley-O'Carroll KF, Li G. Yang M, et al. Among authors: massad k. Immunometabolism (Cobham). 2024 Jan 25;6(1):e00037. doi: 10.1097/IN9.0000000000000037. eCollection 2024 Jan. Immunometabolism (Cobham). 2024. PMID: 38283696 Free PMC article. Review.
Identification of patient subgroups who benefit from a behavioral intervention to improve adjuvant endocrine therapy adherence: a randomized-controlled trial.
Walsh EA, Post K, Massad K, Horick N, Antoni MH, Penedo FJ, Safren SA, Partridge AH, Peppercorn J, Park ER, Temel JS, Greer JA, Jacobs JM. Walsh EA, et al. Among authors: massad k. Breast Cancer Res Treat. 2024 Apr;204(3):547-559. doi: 10.1007/s10549-023-07228-z. Epub 2024 Jan 17. Breast Cancer Res Treat. 2024. PMID: 38231313 Clinical Trial.
A telehealth intervention for symptom management, distress, and adherence to adjuvant endocrine therapy: A randomized controlled trial.
Jacobs JM, Post K, Massad K, Horick NK, Walsh EA, Cohn J, Rapoport CS, Clara AJ, Antoni MH, Safren SA, Partridge AH, Peppercorn JM, Park ER, Temel JS, Greer JA. Jacobs JM, et al. Among authors: massad k. Cancer. 2022 Oct 1;128(19):3541-3551. doi: 10.1002/cncr.34409. Epub 2022 Aug 4. Cancer. 2022. PMID: 35924869 Free PMC article. Clinical Trial.
Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer.
Quinn JM, Greenwade MM, Palisoul ML, Opara G, Massad K, Guo L, Zhao P, Beck-Noia H, Hagemann IS, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Fuh KC. Quinn JM, et al. Among authors: massad k. Mol Cancer Ther. 2019 Feb;18(2):389-398. doi: 10.1158/1535-7163.MCT-18-0537. Epub 2018 Nov 26. Mol Cancer Ther. 2019. PMID: 30478151 Free PMC article.